India Glycols Ltd

Q4 FY26Beverages

India Glycols Q4 FY26 earnings call: Revenue & Margins

Q4 FY26 earnings call: what management guided on revenue, margins and order book.

Price₹1,146

Market cap₹7.1K Cr

P/E22.4

Updated23 Aug 2026

Read4 min read

What the Q4 FY26 call signalled

2 of 4 strong

RevenueModerate growth

MarginMargins steady

CapexCapex planned

FundraiseFundraise planned

The short version

Potable Spirits segment is growing with shift towards premiumization and introduction of new premium brands; IMFL revenue share increased to ~31%, with Amrut contributing 5-6%. Chemicals business: Expectation of improved profitability and top-line growth driven by performance chemicals, new products, and niche markets.

From India Glycols Ltd's Q4 FY26 earnings-call transcript · updated 23 Aug 2026.

Revenue & Sales Performance

Moderate growth

Potable Spirits segment is growing with shift towards premiumization and introduction of new premium brands; IMFL revenue share increased to ~31%, with Amrut contributing 5-6%.
Bio-Fuels business expects continued growth driven by government policies to increase ethanol blending beyond 20% and introduction of flexi-fuel vehicles.
Chemicals segment shows strong growth in performance chemicals (up 40%) and expects to double the business this year, driven by new product development and higher-value chemicals.
Ennature Biopharma is on a growth trajectory focusing on branded nutraceuticals with expansion into US and Asia Pacific markets, backed by clinical studies.

2 more points management made on revenue & sales performance

Profitability & Margins

Chemicals business: Expectation of improved profitability and top-line growth driven by performance chemicals, new products, and niche markets. Cautiously optimistic with potential upside projects underway.
Potable Spirits: Steady growth with premiumization strategy; EBIT margins maintained around 22%. Growth in IMFL segment and new areas like CSD and paramilitary expected to drive continued profitability.
Bio-Fuels: Strong growth with over 40% increase in top-line and doubling of EBIT in FY26; industry expected to sustain reasonable margins due to supportive government policies and potential blending percentage increases beyond 20%.

2 more points management made on profitability & margins

See what India Glycols Ltd said on profitability & margins — free account, 30 seconds.

Capital Expenditure Plans

Capex planned

INR 830 crores capital expenditure in current year, primarily invested in two grain distilleries: Gorakhpur and Kashipur (~INR 400 crores).
Additional smaller capex projects recently completed.
Plans for ongoing reduction of debt with target prepayments in FY '26-'27 totaling INR 268 crores.
Continued investments in Ennature Biopharma segment focusing on manufacturing capability expansion and customer acquisition, aiming for volume growth and profitability improvement.
Focus on premiumization and expansion in Potable Spirit segment with introduction of premium brands, supporting revenue growth.
Multiple ongoing projects in Chemicals business, including carbon smart materials, oilfield chemicals, bio-based amines, dibasic esters, and personal care ingredients, with significant upside potential.

2 more points management made on capital expenditure plans

Top-ranked in Beverages

Ranked on what management guided this quarter

5x potential

1Piccadily Agro₹6.0K Cr

Rev 1Mar 3

2Varun Beverages₹1.5L Cr

Rev 2Mar 3

3₹592 Cr

Rev 2Mar 3

4₹20.0K Cr

Rev 3Mar 1

5₹14.4K Cr

Rev 3Mar 1

Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.

Fundraising & Capital Structure

The company has recently prepaid around INR 804 crores of debt in the quarter, funded partly by INR 467 crores from a November 2025 equity issue and the rest from cash flow.
There is a target to further reduce debt, with INR 268 crores liabilities due in FY26-27 and plans for prepayment based on cash flow, though no fixed amount is committed yet.
Interest cost is expected to reduce from current levels (around INR 25-26 crores per quarter).
Regarding equity fundraising, no mention of upcoming equity issues beyond the November 2025 infusion was made.

2 more points management made on fundraising & capital structure

See what India Glycols Ltd said on fundraising & capital structure — free account, 30 seconds.

Order Book & Pipeline

The transcript does not explicitly mention details on the current or expected order book or pending orders for India Glycols Limited. However, some related points can be inferred: - The nicotine business is in focus, with efforts on acquiring value-added, long-term customers to support growth and profitability (Page 17). - Ennature Biopharma expects growth and recovery driven by branded nutraceutical launches and new certifications (Page 8). - The Chemicals business is diversifying with new products and has a strong pipeline expected to drive growth (Page 8).

2 more points management made on order book & pipeline

India Glycols Ltd — Quarterly revenue & net profit

Revenue Net profit

Dec 2024

Mar 2025

Jun 2025

Sep 2025

Dec 2025

Mar 2026

Reported quarterly figures (₹ Cr). Latest: revenue ₹976 Cr, net profit ₹87 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.

Full financials →

What India Glycols's management said in earlier quarters

Others in Beverages this season

United Breweries Ltd (Q4 FY26)
The document provided is a letter from United Breweries Limited regarding the transcript of their Q4FY2025-26 earnings call. Key concall takeaways from United…
Piccadily Agro (Q4 FY26)
IMFL segment driving majority of growth, with 63% quarterly and ~31% annualized growth currently. Key concall takeaways from Piccadily Agro's Q4 FY26 earnings…
BCL Industries (Q4 FY26)
Current net debt as of March '26 stands around INR 300-335 crores, with interest cost under 7%, including INR 120 crores at subsidized rates. Key concall…
Radico Khaitan (Q4 FY26)
Total IMFL volume in Q4 FY26 grew by **4% year-on-year**. Key concall takeaways from Radico Khaitan's Q4 FY26 earnings call — and how it ranks against sector…

Compare:vs Varun Beverages vs United Spirits Ltd vs Radico Khaitan

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

Frequently Asked Questions

What were India Glycols Ltd Q4 FY26 results?

What is India Glycols Ltd share price analysis?

India Glycols Ltd currently shows a below-average growth signal. The stock trades at a P/E of 22.4 with a market cap of ₹7,112 Cr. Investors should review the full earnings analysis for detailed insights.

Is India Glycols Ltd planning capital expenditure?

INR 830 crores capital expenditure in current year, primarily invested in two grain distilleries: Gorakhpur and Kashipur (~INR 400 crores).

Keep India Glycols Ltd on your radar — track it to get its next earnings analysis in your feed.

This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.